In the current trading session, CTI BioPharma Corp.’s (CTIC) stock is trading at the price of $6.91, a fall of -0.65% over last night’s close. So, the stock is trading at a price that is -3.43% less than its 52-week high of $7.15 and 382.87% better than its 52-week low of $1.43. Based on the past 30-day period, the stock price is -2.80% below the high and +21.50% above the low.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, CTIC’s SMA-200 is $3.87.
Furthermore, one should take into account the price to sales ratio of a company for the last year, which is 328.80.
How does CTI BioPharma Corp. (CTIC) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 5 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.80 in simple terms.
CTI BioPharma Corp. (CTIC): Earnings History
If we examine CTI BioPharma Corp.’s recent earnings history, in the last quarter ended on 12/30/2021, it posted adjusted earnings per share of -$0.38, beating the consensus of -$0.28. In other words, it beat the consensus by -$0.1, resulting in a -35.70% surprise. In the 3 months period before the previous quarter which was closed on 12/30/2021, the stock recorded adjusted earnings per share of -$0.38 in contrast with the Outlook of -$0.28. That was a difference of -$0.1 and a surprise of -35.70%.
CTI BioPharma Corp. (CTIC): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 3 different analysts, who are expecting earnings to fall in between the range of -0.18 and -0.23 with an average Earnings Estimate of -0.20 which is in contrast with the last year earnings estimate of -0.21 and also replicates 4.76% growth rate year over year.
CTI BioPharma Corp. (NASDAQ: CTIC) Ownership Details
I will give a breakdown of the key shareholders in CTI BioPharma Corp. (CTIC). Recent figures show that the company’s insiders hold 0.22% of shares. A total of 97 institutional investors hold shares in the company, making 55.32% of its stock and 55.44% of its float.
Dec 30, 2021, it was reported that the Company’s largest institutional holder is BVF Inc. holding total of 8.93 million shares that make 8.84% of the company’s total number of shares and are currently priced at 22.15 million.
The securities firm Stonepine Capital Management, LLC holds 8.8 million shares of CTIC, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 8.71%, and the holding percentage of shares is valued at 21.82 million.
An overview of CTI BioPharma Corp.’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests CTI BioPharma Corp. (CTIC) traded 3,605,605 shares per day, with a moving average of $6.48 and price change of +0.70. With the moving average of $5.99 and a price change of +2.08, about 4,707,012 shares changed hands on average over the past 50 days. Finally, CTIC’s 100-day average volume is 4,193,542 shares, alongside a moving average of $5.32 and a price change of +2.46.